Maxigen Biotech Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was TWD 111.009 million compared to TWD 103.326 million a year ago. Operating income was TWD 21.522 million compared to TWD 8.637 million a year ago. Net income was TWD 21.620 million compared to TWD 10.186 million a year ago. Basic earnings per share was TWD 0.31 compared to TWD 0.15 a year ago.